Related Experiment Video
Updated: May 2, 2026

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
Multiplex amplicon sequencing reveals polyclonality and low macrolide resistance in the French Mycoplasma pneumoniae
Jennifer Guiraud1, Christophe Ginevra2, Cécile Laurier-Nadalié1
1CHU Bordeaux, Bacteriology Department, Bordeaux, France.
Objectives:
Unprecedented global increases in Mycoplasma pneumoniae respiratory infections began in late summer 2023. Although a predominance of p1 subtype 1 associated with alarmingly high rates of macrolide resistance was reported in Southeast Asia, data from Europe remain limited. We aimed to characterise the circulating M. pneumoniae strains in French hospitalised patients, using a high-throughput amplicon sequencing approach.
Methods:
Phylogenetic analysis was performed using p1 adhesin gene subtyping and multi-locus sequence typing. Mutations associated with antibiotic resistance were screened in the 23S and 16S rRNA, rplD, rplV, gyrA, and parC genes.
Results:
Although most patients (835/933; 89.5%) presented with respiratory symptoms, extrapulmonary manifestations were observed in 49/884 (5.5%) patients. Five p1 subtypes and 29 distinct sequence types were identified, with a predominance of p1 subtype 2 (67.2%) and ST14 (29.7%). Subtype 2 was more frequent in adults, whereas subtype 1 was more often associated with extrapulmonary manifestations. Macrolide resistance-associated mutations were observed at a 3.0% prevalence, exhibiting a trend toward subtype 1 and high frequency of mixed populations. No mutations clearly associated with fluoroquinolone or tetracycline resistance were identified.
Conclusion:
This study demonstrates the polyclonal spread of M. pneumoniae strains and a low prevalence of macrolide resistance during the 2023-2024 outbreak in France.
Insights
The 2023-2024 Mycoplasma pneumoniae outbreak in France showed diverse strains, with p1 subtype 2 predominating. Macrolide resistance remains low overall, though some strains showed resistance mutations.
Area of Science:
- * Medical Microbiology
- * Infectious Diseases
- * Genomic Epidemiology
Background:
- * Global surge in Mycoplasma pneumoniae infections noted since late summer 2023.
- * Previous reports from Southeast Asia indicated p1 subtype 1 predominance and high macrolide resistance.
- * Limited European data on circulating M. pneumoniae strains and resistance patterns during this outbreak.
Purpose of the Study:
- * To characterize Mycoplasma pneumoniae strains prevalent in French hospitalized patients during the 2023-2024 outbreak.
- * To investigate the genetic diversity and antibiotic resistance profiles of circulating strains.
- * To utilize high-throughput amplicon sequencing for detailed strain analysis.
Main Methods:
- * Phylogenetic analysis employing p1 adhesin gene subtyping and multi-locus sequence typing (MLST).
- * Screening for antibiotic resistance-associated mutations in key genes (23S rRNA, 16S rRNA, rplD, rplV, gyrA, parC).
- * Analysis of clinical data, including respiratory and extrapulmonary manifestations.
Main Results:
- * Identified five p1 subtypes and 29 distinct sequence types (STs), with p1 subtype 2 (67.2%) and ST14 (29.7%) being most frequent.
- * P1 subtype 2 was more common in adults, while subtype 1 was linked to extrapulmonary manifestations (5.5% of cases).
- * Low prevalence (3.0%) of macrolide resistance-associated mutations observed, with a trend towards subtype 1 and mixed populations; no fluoroquinolone or tetracycline resistance mutations detected.
Conclusions:
- * The 2023-2024 Mycoplasma pneumoniae outbreak in France involved polyclonal strain spread.
- * A low prevalence of macrolide resistance was documented in the studied French population.
- * Further surveillance is needed to monitor evolving resistance patterns and strain dynamics.
Related Concept Videos
Modern Molecular Taxonomy
Atypical Pneumonia
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

